Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
22 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ideaya-biosciences-and-hengrui-pharmaceuticals-announce-oral-presentation-at-iaslc-2025-world-conference-on-lung-cancer-for-ide849-shr-4849-a-potential-first-in-class-dll3-top1-adc-302510323.html
05 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hengrui-pharma-showcases-global-impact-at-the-2025-asco-72-study-results-highlight-chinese-cancer-innovation-302474128.html
01 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hengruis-camrelizumab-combo-therapy-doubles-the-five--year-survival-of-patients-with-advanced-squamous-lung-cancer---a-potential--paradigm-shift-in-clinical-outcome-for-this-difficult-to-treat-population-302416809.html
29 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ideaya-biosciences-enters-exclusive-license-with-hengrui-pharma-for-shr-4849-a-novel-phase-1-dll3-topo-i-payload-adc-targeting-sclc-and-net-solid-tumors-302339847.html
18 Jan 2020
// Angus Liu FIERCE PHARMA
https://www.fiercepharma.com/pharma-asia/hengrui-s-sun-piaoyang-china-s-richest-pharma-leader-sort-steps-down-after-30-year-run
11 Oct 2018
// Angus Liu FIERCE PHARMA
https://www.fiercepharma.com/pharma-asia/big-pharma-s-cancer-drugs-take-50-plus-discount-for-china-s-insurance-scheme
Inspections and registrations
ABOUT THIS PAGE